Jill A Helms, Age 6615 Los Charros Ln, Menlo Park, CA 94028

Jill Helms Phones & Addresses

15 Los Charros Ln, Portola Vally, CA 94028 (650) 799-7570

Portola Valley, CA

3767 Redwood Cir, Palo Alto, CA 94306 (650) 213-8220

9 Loyola Ter, San Francisco, CA 94117 (415) 752-3929

765 Mangels Ave, San Francisco, CA 94127 (415) 585-7515

Houston, TX

Mentions for Jill A Helms

Jill Helms resumes & CV records

Resumes

Jill Helms Photo 36

Chief Scientific Officer

Location:
15 Los Charros Ln, Portola Valley, CA 94028
Industry:
Research
Work:
Ankasa Regenerative Therapeutics
Chief Scientific Officer
Follow Your Bliss Farm 2005 - 2014
Owner
Stanford University 2005 - 2014
Professor
Ucsf 1996 - 2004
Associate Professor
Education:
Stanford University
University of Minnesota
Roosevelt High School
Skills:
Cell Biology, Molecular Biology, Teaching, Cell, Stem Cells, Cell Culture, Laboratory, Research, Life Sciences, Science, Biochemistry, Medicine, Genetics, Clinical Research
Languages:
English
Jill Helms Photo 37

Jill Helms

Jill Helms Photo 38

Jill Helms

Jill Helms Photo 39

Jill Helms

Skills:
Photoshop, Microsoft Office, Management, Microsoft Word, Microsoft Excel, English, Process Improvement, Sales, Outlook
Jill Helms Photo 40

Jill Helms

Jill Helms Photo 41

Jill Helms

Location:
United States

Publications & IP owners

Us Patents

Use Of Liposomal Wnt Composition To Enhance Osseointegration

US Patent:
2012011, May 10, 2012
Filed:
Sep 9, 2011
Appl. No.:
13/199820
Inventors:
Jill Helms - Stanford CA, US
International Classification:
A61K 38/17
A61P 19/08
US Classification:
514 167
Abstract:
Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

Wnt Compositions And Methods Of Use Thereof

US Patent:
2008022, Sep 18, 2008
Filed:
Mar 5, 2008
Appl. No.:
12/074766
Inventors:
Jill Helms - Stanford CA, US
Roeland Nusse - Stanford CA, US
Jaebeom Kim - Mountain View CA, US
Philipp Leucht - Woodside CA, US
International Classification:
A61K 9/127
A61K 38/17
A61P 19/00
US Classification:
424450, 514 12
Abstract:
Methods and compositions are provided for the therapeutic use of Wnt proteins, where the Wnt protein is inserted in the non-aqueous phase of a lipid structure. In some embodiments the Wnt protein is presented in its active conformation on an outer liposome membrane or micelle. Pharmaceutical compositions of the present invention can be administered to an animal for therapeutic purposes. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

Use Of Liposomal Wnt Compositions To Enhance Osseointegration

US Patent:
2023005, Feb 16, 2023
Filed:
Aug 24, 2022
Appl. No.:
17/822045
Inventors:
- Stanford CA, US
Jill Helms - Stanford CA, US
International Classification:
A61K 38/17
A61K 9/127
C07K 14/475
A61K 9/00
Abstract:
Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

Wnt Compositions And Methods Of Process From Serum-Free Culturing Conditions

US Patent:
2020039, Dec 24, 2020
Filed:
Aug 18, 2020
Appl. No.:
16/996676
Inventors:
- La Jolla CA, US
Jill Helms - Portola Valley CA, US
Ying Zhu - Palo Alto CA, US
Bo Liu - Palo Alto CA, US
Stefanie Gaster - La Jolla CA, US
International Classification:
C12N 5/00
C07K 1/18
A61K 47/26
A61K 47/69
C12N 5/071
Abstract:
Disclosed herein are methods and compositions for producing a Wnt polypeptide under a serum-free condition. Also disclosed herein are methods of purifying the Wnt polypeptide from a serum-free condition.

Use Of Liposomal Wnt Compositions To Enhance Osseointegration

US Patent:
2019020, Jul 4, 2019
Filed:
Nov 8, 2018
Appl. No.:
16/184705
Inventors:
- Stanford CA, US
Jill Helms - Stanford CA, US
International Classification:
A61K 38/17
A61K 9/00
A61K 9/127
C07K 14/475
Abstract:
Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

Use Of Liposomal Wnt Composition To Enhance Osseointegration

US Patent:
2014037, Dec 18, 2014
Filed:
Jul 22, 2014
Appl. No.:
14/337718
Inventors:
- PALO ALTO CA, US
Jill Helms - Stanford CA, US
International Classification:
A61K 38/17
A61K 9/00
A61K 9/127
US Classification:
514 167
Abstract:
Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.